News Summary

• Miraqules developed a nanotechnology in powder form that mimics blood clotting proteins.
• The powder rapidly produces fibrous compounds at room temperature that are a high volume to ratio and can absorb blood quickly when applied.
• Miraqules is a Top 20 Startup Battlefield finalist and will be presenting this technology on stage at TechCrunch Disrupt 2025.
• The company expects to get its regulatory clearance in India within the next few months.
• It also is on track to receive clearance from the U.S. Food and Drug Administration in 2026.